X

Trial Profile

A Phase 1 Clinical Trial to Explore Pharmacokinetics, Pharmacodynamics and Safety After Twice-daily Dosing of Tegoprazan Tablets in Healthy Subjects

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 05 Aug 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tegoprazan (Primary) ; Esomeprazole
Indications Erosive oesophagitis; Gastric ulcer; Gastro-oesophageal reflux; Helicobacter infections
Focus Pharmacokinetics
Sponsors HK inno.N

Most Recent Events

23 Dec 2020 Planned number of patients changed from 64 to 40.
23 Dec 2020 Planned End Date changed from 1 Sep 2021 to 1 Jun 2021.
23 Dec 2020 Planned primary completion date changed from 1 Jun 2021 to 1 Mar 2021.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com